Logo

RheoGene Licenses Technology to Xenogen Biosciences to Develop Transgenic Mice

Sep 16, 2005

NEW YORK, Sept. 16 (GenomeWeb News) - RheoGene has licensed its RheoSwitch System technology to Xenogen Biosciences to develop transgenic mice as animal research models.

 

"The objective of this research collaboration is to establish and validate RheoSwitch technology within the transgenic mouse setting through the creation of genetically modified animals," said Thomas Tillett, RheoGene's president and CEO.

 

The companies will also collaborate on several projects aimed at controlling delivery and regulating expression of RNAi in order to address the problems of timing and localizinf active RNAi products to various target sites in vivo.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.